Lenti-ALK CAR (scFv-28ζ, hALK58)-VP(VP-CAR-LC610)
The ready-to-use lentiviral particles of Lenti-ALK CAR (scFv-28ζ, hALK58)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of CAR will be driven by a CMV promotor. The target gene of scFv (hALK58)-CD28-CD3ζ packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
Type of Therapeutics
Chimeric Antigen Receptor
Non-small cell lung cancer (NSCLC)
This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).
ALK; anaplastic lymphoma receptor tyrosine kinase; CD246; NBLST3
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
||Anti-ALK (ALK15) h(CD28-41BB-CD3ζ) CAR, pCDCAR1
||Anti-ALK (hALK48SH) h(41BB-CD3ζ) CAR, pCDCAR1
||Lenti-ALK CAR (scFv-CD28-CD3ζ, ALK53) Viral Particle
||Lenti-ALK CAR (scFv-CD28-CD3ζ, ALK48) Viral Particle
||Anti-ALK (ALK53) h(CD28-41BB-CD3ζ) CAR, pCDCAR1
||Anti-ALK (ALK58) h(CD28-CD3ζ) CAR, pCDCAR1
||Anti-ALK (ALK15) h(CD28-CD3ζ) CAR, pCDCAR1
||Anti-ALK (ALK53) h(41BB-CD3ζ) CAR, pCDCAR1
||Anti-ALK (hALK53) h(CD28-CD3ζ) CAR, pCDCAR1
||Anti-ALK (ALK53) h(CD28-CD3ζ) CAR, pCDCAR1